Kaneka Corporation, the Japan based chemical manufacturing company, is set to appeal to the District Court for the Centr...
Aquinox Pharmaceuticals, a clinical-stage pharmaceutical company discovering and developing novel drug candidate...
Singapore– Takeda Pharmaceutical agreed to buy London-listed Shire for 45.3 billion pounds ($61.50 billion) a...
Japanese drugmaker Ono Pharmaceutical has submitted a new drug application for the approval of pheochromocytoma (PCC) tr...
Aspirin can counter the ill effects of obesity on cancer development, according to a study that may pave the way for new...
Takeda Pharmaceutical Co. reached a preliminary agreement to buy Shire Plc with takeover offer of about 46 billion pound...
Japan based Aska Pharmaceuticals Co. and Omnicare Drugs India Pvt Ltd, a 100 per cent subsidiary of the UAE's largest ph...
Taiwan and Japan authorities have urged locals and tourists to take added precautions following an outbreak of measles. ...
Singapore- Japan’s Astellas Pharma and Kite Pharma, a Gilead Sciences subsidiary announced that an agreement has b...
Singapore- Drugmaker Shire has rejected a third takeover bid worth nearly $63 billion from Japan's Taked...
The engineering and IT conglomerate Hitachi is poised to carry out what it hailed as the world’s first experiment ...
Fujitsu Laboratories Ltd. has announced the development of AI technology that uses deep learning to detect objects, even...
A team of Japanese researchers has developed a new compound that enhanced motor function recovery after brain damage in ...
Singapore – Takeda appears to be preparing its bid for rare diseases pharma Shire, reportedly sounding out major c...
Hitachi Ltd. has received an order for a heavy ion therapy system from the Taipei Veterans General Hospital (Deh-Ming Ch...
Singapore – Rhythm Pharmaceuticals acquires exclusive global rights to Takeda Pharmaceutical Company's T-3525770 (...
Southeast Asia's largest medical device company, Accuron MedTech Group, today announced the completion of ...
Fujifilm intends to expand its ability to develop and manufacture biopharmaceuticals and regenerative medicine treatment...
